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Abstract Formation of amyloid-like fibrils in a solution of 
human islet amyloid polypeptide (hIAPP) with and without the 
presence of other IS-cell granule components was studied in vitro. 
Insulin at less than equimolar concentration strongly inhibited 
hIAPP fibrillogenesis. Proinsulin had a weaker inhibitory effect 
while C-peptide, Ca 2+ and Zn 2÷ each individually enhanced fibril 
formation. C-peptide combined with Ca 2+ had an inhibitory ef- 
fect. Since IAPP was found almost exclusively in the halo frac- 
tions of isolated islet secretory granules, primarily the concentra- 
tions of C-peptide, Ca 2+ and possibly proinsulin may be crucial 
for the native state of IAPP. It is concluded that an imbalance 
between fibril formation enhancers and inhibitors may be of im- 
portance in the pathogenesis of amyloid in the islets of Langer- 
hans. 
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loid properties in vitro while corresponding rat IAPP peptides 
do not [10]. This fibril formation of hIAPP occurs rapidly and 
spontaneously in aqueous olutions. 
With this knowledge, we hypothesized that there normally 
may exist a mechanism which hinders the formation of amyloid 
fibrils from IAPP in fl-cells and in the islets of Langerhans, the 
only sites where it is expressed at high concentrations. Since 
IAPP is stored together with insulin, proinsulin and C-peptide 
in the secretory granules, the influence of these three latter 
polypeptides on fibril formation was studied in vitro. Both 
calcium and zinc are present at high concentration i the fl-cell 
secretory granules and therefore the effect of these ions on fibril 
formation was included in the investigation. Finally, we deter- 
mined the concentration of IAPP in the two fl-cell granule 
compartments. 
2. Materials and methods 
I. Introduction 
Islet amyloid polypeptide (IAPP) is a 37 amino acid residue 
polypeptide, mainly expressed in fl-cells [1]. It is in human a 
product of a 69 amino acid precursor by cleavage at double 
basic amino acid residues [2-4]. IAPP is stored together with 
insulin, C-peptide and some other peptides in the fl-cell secre- 
tory granules [5] and the components are released together at 
exocytosis. The normal function of IAPP is poorly understood 
but its structure supports a putative hormonal role [6]. A mul- 
titude of effects have been obtained experimentally and func- 
tions as glucoregulatory hormone, calcium regulating polypep- 
tide or appetite regulator have been proposed (reviewed in [7]). 
Autocrine and paracrine ffects have also been implicated. The 
role of IAPP in the development of diabetes is not known. 
IAPP gives rise to amyloid deposits in human islets of 
Langerhans and deposition of amyloid is the most characteris- 
tic islet lesion in non-insulin-dependent diabetes mellitus 
(N IDDM) [8]. Amyloid forms by aggregation of IAPP into 
characteristic thin fibrils. The reason for islet amyloid develop- 
ment is incompletely understood but an obvious prerequisite 
for amyloid fibril formation is an amyloidogenic amino acid 
sequence, present in a central segment (positions 24-29) of 
IAPP in human, cat and raccoon but not in mouse, rat or 
hamster [6,9]. Thus, both full length human IAPP and a central 
fragment of human lAPP (hIAPP20-29) form fibrils with amy- 
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2. l. Polypeptides and chemicals 
Human full-length IAPP ('amylin') was from Peninsula (Belmont, 
CA). Human C-peptide was from Eli Lilly (Indianapolis, IN) and C- 
terminally acetylated human C-peptide was synthesized by Chiron 
Mimotopes Peptide Systems (Clayton, Victoria, Australia). Human 
insulin (humulin) and proinsulin were from Eli Lilly. Human C-peptide 
was dissolved (40 mg/ml) in distilled water. All other polypeptides were 
dissolved in dimethylsulfoxide (DMSO), IAPP at a concentration f 10 
mg/ml and insulin, proinsulin and acetylated C-peptide at a concentra- 
tion of 40 mg/ml. Zinc chloride and calcium chloride were dissolved in 
distilled water at a concentration of 100 mmol/l. 
2.2. In vitro fibril formation 
The in vitro fibril formation experiments were performed in 50/zl 
batches in small glass test tubes and all experiments were performed at 
least wo times. The final concentration f IAPP was always 250/tmol/1. 
The peptides were mixed in two different ways. In one series of exper- 
iments, C-peptide and/or insulin was diluted with double distilled water 
to an appropriate concentration. IAPP was then added and mixed in 
vigorously. In another series of experiments with identical final 
polypeptide concentrations, polypeptide solutions and DMSO were 
first mixed and water was then added. The concentrations of insulin and 
C-peptide varied (Tables 1 and 2) while the final amount of DMSO and 
water was identical in all samples. When calcium or zinc chloride was 
included, polypeptide solutions and DMSO were first mixed, CaC12 or 
ZnCI 2 thereafter added and finally water. The final pH in all the mix- 
tures was between 5 and 6, as estimated by spotting aliquots on pH 
paper. The mixtures were left at room temperature [10] and after incu- 
bation for 15 min, 1, 2 and 4 days and in some experiments 2 weeks, 
the mixtures were inspected for appearance ofvisible precipitate. Drop- 
lets (1 /tL) were air-dried on glass slides, stained with alkaline Congo 
red and examined in a polarization microscope for green birefringence, 
typical of amyloid. Occurrence of amyloid-like material was semiquan- 
titatively estimated according to a score from 0 to 4 +. 
In some preparations the diameter (arbitrary units) of 25 randomly 
chosen amyloid-like particles was measured inthe light microscope with 
the aid of a scale in the eyepiece. 
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Other droplets were diluted 1:10 with distilled water, placed on 
formvar-coated copper grids, negatively contrasted with 1% sodium 
phosphotungstate nd studied in a Jeol 1200 electron microscope at 
80 kV. 
2.3. Analysis of IAPP-C-peptide aggregates 
For further studies of the incorporation of C-peptide in the fibrils, 
reversed phase high performance liquid chromatography (RP-HPLC) 
was performed. Selected samples of IAPP/C-peptide mixtures were 
washed with distilled water, centrifuged and the small pellet lyophilized. 
The pellets were dissolved in 40/~1 70% formic acid and applied to a 
TSK ODS 120 T C~8 HPLC column (LKB, Bromma, Sweden). The 
material was eluted from the column with a linear gradient of 70% 
acetonitrile in 0.1% trifluoroacetic acid and the eluate was monitored 
at 226 nm. 
2.4. Glycation and solubility of lAPP-fibrils 
Fibrils, made from IAPP and stored at room temperature for 1 and 
5 months, respectively, were tested. In order to test whether glycation 
of lAPP affects fibril solubility, 5-month-old fibrils were glycated in 
vitro. For this, fibrils were incubated in the presence of 0.5 M glucose 
for 15 days at +37°C, as described [11,12]. 
IAPP fibrils (50 pg) were suspended for 5 h in 1 ml 6 M guanidine 
HCI in 0.1 M Tris HC1 buffer, pH 8.0, containing 0.1 M dithiothreitol. 
The suspension was centrifuged, washed with distilled water and exam- 
ined for the presence of amyloid-like fibrils. 
2.5. Analysis of lAPP and insulin in islet r-cell granule compartments 
Islets from 9 female FVB/N mice, 3-6 months old, were isolated by 
the collagenase method [13], and secretory granule-enriched fractions 
were prepared, lysed and separated by discontinuous sucrose gradient 
ultracentrifugation, i to pH 5.4 soluble (halo) and insoluble (core) 
fractions as described [14]. The concentration finsulin in the fractions 
was determined by an insulin radioimmunoassay kit (Pharmacia, 
Uppsala, Sweden) with rat insulin as standard. IAPP was determined 
by a previously described radioimmunoassay [15], with rat/mouse lAPP 
as standard. 
2.6. Statistics 
When applicable, values are given as mean + S.E.M. For comparison 
of means, the Mann-Whitney unpaired non-parametric test was used. 
3. Results 
3.1. IAPP fibrils 
Dilution of the IAPP solution with water resulted in Congo 
red-positive material that was visible within 12 h. The fibrils 
tended to aggregate and after 48-96 h much of the material 
appeared in the light microscope as small often rounded parti- 
cles which showed strong affinity for Congo red giving a bright 
green birefringence after such staining. Electron microscopi- 
cally, amyloid-like, fine fibrils of  about 75/~ in width were seen 
(Fig. 1). They were usually less than 500 nm long. Commonly, 
two or more fibrils were aggregated into small bundles. No 
amorphous material was seen electron microscopically. 
3.2. Effects of C-peptide 
When lAPP was added to any of the tested concentrations 
of C-peptide, a fine precipitate was formed rapidly. When 
stained with Congo red, large homogeneous and, compared to 
pure lAPP-fibrils, more weakly stained aggregates appeared, 
which exhibited a green birefringence (Table 1). Congo red- 
positive material appeared more rapidly as compared with pure 
lAPP and was visible already after 1 h. The amount of such 
material increased with increasing C-peptide concentration. 
Both C-peptide preparations behaved identically. Electron mi- 
croscopically, fibrils appeared that often were longer as com- 
pared to the fibrils formed from pure 1APP. Furthermore, large 
aggregates of sometimes parallel fibrils were commonly seen 
(Fig. 1B). Some amorphous material also appeared. The two 
different ways of mixing the peptides gave identical results. 
C-peptide alone did not give rise to fibrils. 
3.3. Effects of  insulin and proinsulin 
Dilution with water of the insulin solution resulted in a visi- 
ble precipitate, except at the lowest tested insulin concentra- 
tion. The precipitate did not bind Congo red and showed white 
but no green birefringence. When lAPP was added to a solution 
containing 170-1400 pmol/1 insulin, no amyloid-like material 
was found light or electron microscopically (Table 2). Even at 
lower concentrations, insulin significantly inhibited lAPP fibril 
formation (Table 2). In the mixtures of  proinsulin and lAPP a 
small amount of  amyloid-like material was seen but much less 
than in the IAPP-C-peptide mixtures or when lAPP alone was 
diluted with water. The mixtures containing lAPP (250/~mol/1), 
insulin (700 pmol/1) and C-peptide (650 pmol/1) behaved like 
those containing only lAPP and insulin. Thus, in the presence 
of insulin, C-peptide did not enhance fibril formation. 
The above results did hold true for a period of 2 days to more 
than l week of incubation at room temperature. However, 
when the polypeptide mixtures were allowed to incubate for 
more than 2 weeks at room temperature, some material stained 
like amyloid by Congo red appeared. 
3.4. Effects of zinc and calcium 
Zinc chloride concentration-dependently enhanced forma- 
tion of amyloid-like material (Table 3). When lAPP was incu- 
bated with 100-500 pmol/1 of zinc chloride, more and larger 
Congo red-positive particles appeared compared to material 
formed from lAPP alone (diameters of  amyloid-like particles 
at 0 and 200/,tmol/1 of Zn 2+ were 0.50 + 0.08 and 1.25 + 0.14 
arbitrary units, respectively, P < 0.001). Electron microscopi- 
Table 1 
Effect of different islet r-cell granule components on the formation of 
amyloid-like fibrils from a solution of human lAPP 
IAAP Proinsulin C-peptide Amyloid score 
250 900 - 0 
250 450 - 2+ 
250 225 - 2+ 
250 - 1300 3-4+ 
250 - 650 3-4+ 
250 - 3+ 
All values are/lmol/l. 
Table 2 
Effect of various concentrations of insulin on the formation of amyloid- 
like fibrils from a 250/tmol/1 solution of human IAPP 
Insulin concen- 0 17 35 85 170 700 1400 
tration ~mol/1) 
Amyloid score 3 + 1 + 1 + 1 + 0 0 0 
Table 3 
Effect of various concentrations of zinc chloride on the formation of 
amyloid-like fibrils from a 250 pmol/1 solution of human IAPP 
ZnCI 2 concen- 0 25 50 100 200 500 1000 
tration ~umol/1) 
Amyloid score 2 + 2 + 2 + 3 + 4 + 3 + 2 + 
i'i 
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Fig. 1. Fibrils formed from human IAPP. Bar = 200 nm. A: Amyloid- 
like fibrils formed from 1APP. The fibrils are thin, rigid and short. 
B: Fibrils formed from lAPP in the presence of C-peptide. The thin 
fibrils are aggregated into thick bundles. C: Fibrils formed from IAPP 
in the presence of zinc chloride. The fibrils are long and even. 
cally, the fibrils varied in length but many were much longer 
(often > 2/lm) than those formed from lAPP in absence of zinc 
(Fig. 1C). Similar effects, including the occurrence of large 
Congo red-positive particles, were seen with calcium chloride 
which also enhanced fibril formation at the tested concentra- 
tions (5, 10 and 20 mmol/1). In contrast, when lAPP was incu- 
bated with C-peptide (650/.tmol/l) and calcium chloride (10 or 
20 mmol/1), a significant inhibition (amyloid score 1 +) of the 
formation of amyloid-like fibrils occurred. The mixing of insu- 
lin (700 ~tmol/1), C-peptide (650/.tmol/1) and calcium chloride 
(5, 10 or 20 mmol/l) with lAPP completely abolished fibril 
formation. 
3.5. Analysis of the IAPP-C-peptide aggregates 
When the amyloid-like precipitate, which appeared after 
mixing C-peptide with lAPP, was dissolved in formic acid and 
run on RP-HPLC, two peaks of similar size were obtained (not 
shown). The peaks corresponded exactly to the elution posi- 
tions of lAPP and C-peptide, respectively. 
3.6. Solubility of lAPP fibrils 
All lAPP-fibrils tested were insoluble in 6 M guanidine HC1. 
In this respect there was no difference between fibrils that were 
one month old, five months old or glycated in vitro. 
3. 7. IAPP in secretory granules 
The total amount of IAPP was 30-fold higher in pH 5.4 
soluble fractions of secretory granules compared to the insolu- 
ble fractions. The amount ofimmunoreactive insulin was 4-fold 
higher in the fraction containing secretory granule cores com- 
pared to the soluble fractions (Table 4). As seen, the molar 
concentration of immunoreactive insulin in the soluble frac- 
tions is 10 times higher than that of 1APP. It should also be 
noted that the extractable amount of lAPP is about 2% of 
insulin on a molar basis. 
4. Discussion 
Most amyloid fibril proteins are truncated forms derived 
from larger normal or mutant precursors where the precursor 
itself rarely is amyloidogenic. In islet amyloid, so far only full 
length, non-mutant lAPP has been identified. Formation of 
amyloid can be regarded as a form of off-pathway aggregation 
of proteins, possibly from a folding intermediate [16]. Aggrega- 
tion of proteins during the folding process is believed to be 
normally abolished by chaperones. Human lAPP has an unusu- 
ally strong tendency to form amyloid-like fibrils spontaneously 
from aqueous olutions [10]. Therefore, a mechanism that hin- 
ders fibrillogenesis is probably present in the endoplasmic retic- 
ulum and fl-cell secretory granules where lAPP must be present 
at fairly high concentration. 
This study clearly shows that several islet fl-cell granule com- 
ponents affect fibril formation of 1APP. At the pH, at which 
the in vitro experiments were performed, lAPP is positively and 
C-peptide negatively charged, respectively, while insulin is close 
to its isoelectric point. A binding capacity of lAPP to C-peptide 
was therefore xpected and C-peptide not only enhanced the 
fibriUogenesis but was incorporated in the fibrils as revealed by 
the HPLC study. Furthermore, Ca 2÷ and Zn 2÷ each individually 
strongly enhanced formation of amyloid-like material. How- 
ever, C-peptide combined with Ca 2÷ acted as an inhibitor of 
fibrillogenesis. Insulin, alone or in combination with other 
granule components, also turned out to be a potent inhibitor 
of fibrillogenesis. In the pancreas in vivo, the lAPP:insulin 
molar ratio is below 10% (which is in accordance with the 
present study) and even when present at a molar concentration 
much below that, insulin almost completely abolished fibril 
formation in vitro. These results, taken together, indicate that 
a complex balance between different granule components may 
exist that hinders lAPP amyloid formation. Hypothetically, a 
Table 4 
Extractable amount of IAPP and insulin in the soluble and non-soluble 
fractions of mouse beta cell granules 
soluble non-soluble P value 
lAPP 364 + 25 12 + 2 >0.001 
Insulin 3820 + 496 14,320 + 1230 >0.01 
All values are pmol (mean + S.E.M.). 
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disturbance in such a balance may lead to fibrillogenesis. If
such a disturbance r ally occurs in islets with amyloid deposits 
is still to be shown. 
Presence of calcium and zinc gave rise to longer IAPP fibrils 
and strongly increased formation of big amyloid-like particles. 
In the present study, this effect of Zn 2+ was most evident at a 
concentration of 200 pmol/1 which was close to equimolarity 
with IAPP. Zinc, as well as aluminium and iron, has also been 
shown to promote the Alzheimer fl-protein aggregation i  vitro 
[17]. Similar to what was found with IAPP, Zn 2÷ induces large 
amyloid-like particles from fl-protein in vitro and zinc has 
therefore been proposed to play a role in the pathogenesis of
amyloid brain lesion [18]. 
The exact site of normal storage of IAPP in the secretory 
granules has not been studied in detail previously. It has been 
suggested that IAPP most probably occurs in the translucent 
halo [19,20] although in one immune lectron microscopy study 
the strongest IAPP immunoreactivity was found on the granule 
cores [5]. This latter finding could possibly be due to a prepara- 
tion artefact but it could not be ruled out that lAPP is stored 
together with insulin on the granule core surface. The results 
of the present study clearly show that almost all immunoreac- 
tive IAPP goes with the soluble phase of the granules, i.e. the 
halos. Thus, our results how that IAPP is in close contact with 
several components hat may affect fibril formation. Although 
most insulin is found within the granule cores, the concentra- 
tion of insulin and proinsulin-forms in the halo is probably high 
enough to completely abolish fibril formation under normal 
condition. It should be emphasized that calcium when com- 
bined with C-peptide also inhibited IAPP fibrillogenenesis. 
One property that native islet amyloid shares with Aft-amy- 
loid in neuritic plaques in Alzheimer's disease, is its unusual 
resistance to solvents like 6 M guanidine HC1 and 8 M urea 
(solvents that dissolve other types of amyloid fibrils). It has 
been hypothesized that this resistance could be due to some 
secondary phenomenon like cross-linking or glycation of the 
protein. However, the present study indicates that the insolubil- 
ity is a property of the lAPP-fibril as such. 
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